Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Guanidine-dependent poliovirus attenuation shows protection in models; leaves open translation to human vaccine strategies.
Guanidine-dependent polioviruses are obtained in vitro by subculturing Brunenders, Mahoney, and Sabin strains in the presence of increasing concentrations of guanidine. Mahoney viruses dependent on guanidine lose virulence (as indicated by paralysis) for monkeys inoculated intramuscularly or intracerebrally. Protection against virulent Mahoney viruses is induced by treatment with guanidine-dependent strains, and serum antibodies against the virulent strains are present in the treated animals
No takes yet. Share an insight, caveat, or question.
Loddo et al. (1964) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: